Full Archive

They may be high tech but…..

Years ago, when the biggies of tech – Apple, Google and Amazon dived into the diabetes digital/virtual pool we were excited. Our excitement came on several levels but mostly because these were CONSUMER oriented companies who used way cool whiz bang with CONSUMERS. Let’s face it back then the old guard was getting long in the tooth and had yet to adapt to how things were changing. The arrival of...

What it’s all about

When it comes to our wacky world there should be no confusion when it comes to what it’s really all about. As much as we’d like it be about better patient outcomes it isn’t. As much as we’d like it be about making diabetes management as easy as possible it isn’t. Nope in our wacky world it is and will continue to be all about money – who makes it...

More bad news for Medtronic, more good news for Lilly

Not like they needed more bad news Medtronic diabetes got some when they received an FDA warning letter. According to a press release issued this morning- “The warning letter focuses on the inadequacy of specific medical device quality system requirements at the Northridge facility in the areas of risk assessment, corrective and preventive action, complaint handling, device recalls, and reporting of adverse events.” It goes without saying that this is just one more...

This should be fun

As 2021 winds down and 2022 beckons the New Year will begin with a bang as CES looks to be right up our alley. While we doubt Robert Ford CEO of Abbott who’s delivering the keynote address will provide a Libre3 update or mention that Europe has 44 countries. We are anticipating lots of way cool whiz bang wearables, sensors and apps related to our health and wellness. This really...

The future before it happens

It seems each day, yet another Omnipod wannabe pops up on our radar. Which is interesting since we don’t really hear about too many Tandem wannabes. Yes, the patch pump is where the money is and quite frankly what the future will be for the insulin pump space. Write it down in ink folks 10 years maybe a little longer tethered pumps will be a thing of the past. The...

A road map

As we sit and watch the Medtronic diabetes franchise slowly sink into the abyss, we thought we’d offer Mr. Salmon some free advice on how to turn things around before they have another Animas on their hands. Of course, the easiest solution is to sell the unit to Blackstone and walk away. But what happens then? How does Blackstone or any other buyer fix the many issues facing the company? While...

Navigating the IP minefield

When it comes to diabetes devices there are a host of issues that wannabes must navigate. The least talked about and perhaps the most difficult area to navigate is the intellectual property minefield. Next to having an FDA approved product and talented management team a company’s intellectual property portfolio becomes a valuable and useful asset. To fully appreciate just how valuable look no further than the now defunct Cozmo insulin pump....